Comparison Chart BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 10/07/2026 +04			5-day change	1st Jan Change
10.72 ^USD	-3.51%		+11.09%	+37.44%

07-07	RBC Capital Adjusts BioCryst Pharmaceuticals Price Target to $14 From $13, Maintains Outperform Rating	MT
06-29	BioCryst scraps internal drug discovery programs, leans on partnerships to cut costs	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	BIOCRYST PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	-3.51%	+11.09%	+37.44%	+21.96%	-34.03%	2.82B